Syntara Limited has released a press release.
Response to ASX Aware Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Syntara
- PXS Collaborators Receive Government Grants of $1.4m
- Share Purchase Plan
- Security Purchase Plan
- FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study
- Appendix 4C Cash Flow Report
Later from Syntara
- Appendix 4C Quarterly Cash Flow Report
- Clarification Announcement
- Aptar Pharma Pays PXS Us$5m to Acquire Orbital Technology
- PXS to Receive Stg2.9m from Parkinsons UK for New Trial
- PXS Releases Promising Interim Data from Skin Scarring Study
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara